Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31
Phase 41

Trial Status

Completed2
Other1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT03753763Phase 2Completed
Safinamide for Multiple System Atrophy (MSA)
Multiple System Atrophy
StudydirectorStart date: 2019-10-29
NCT03841604Phase 4Completed
Effect of Safinamide on Parkinson's Disease Related Chronic Pain
Idiopathic Parkinson Disease
StudydirectorStart date: 2019-04-09
NCT03987750Phase 3Withdrawn
Safinamide for Levodopa-induced Dyskinesia (PD-LID)
Dyskinesia, Drug-InducedParkinson Disease
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03753763Phase 2StudyDirector

Safinamide for Multiple System Atrophy (MSA)

Multiple System Atrophy
Completed
NCT03841604Phase 4StudyDirector

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

Idiopathic Parkinson Disease
Completed
NCT03987750Phase 3StudyDirector

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Dyskinesia, Drug-InducedParkinson Disease
Withdrawn

All 3 trials loaded